Results of up-front surgery combined with adjuvant chemotherapy for pancreatic head cancer: Adjuvant gemcitabine chemotherapy may be more effective for borderline resectable cases.

Pancreatology ◽  
2014 ◽  
Vol 14 (3) ◽  
pp. S110
Author(s):  
Taku Aoki ◽  
Takeyuki Watadani ◽  
HIroyuki Akai ◽  
Yoshihiro Sakamoto ◽  
Yasuhiko Sugawara ◽  
...  
Keyword(s):  
Adjuvant Chemotherapy ◽  
Pancreatic Head ◽  
Borderline Resectable ◽  
Head Cancer ◽  
Pancreatic Head Cancer

scholarly journals Extended lymphadenectomy benefits patients with borderline resectable pancreatic head cancer—a single-center retrospective study

Gland Surgery ◽  
2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Jing Wang ◽  
Shao-Cheng Lyu ◽  
Ji-Qiao Zhu ◽  
Xian-Liang Li ◽  
Ren Lang ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Pancreatic Head ◽  
Extended Lymphadenectomy ◽  
Single Center ◽  
Borderline Resectable ◽  
Head Cancer ◽  
Pancreatic Head Cancer

Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series

2017 ◽  
Vol 24 (9) ◽  
pp. 2752-2761 ◽  
Author(s):  
Katsuhisa Ohgi ◽  
Yusuke Yamamoto ◽  
Teiichi Sugiura ◽  
Yukiyasu Okamura ◽  
Takaaki Ito ◽  
...  
Keyword(s):  
Pancreatic Head ◽  
Borderline Resectable ◽  
Head Cancer ◽  
Venous Involvement ◽  
Pancreatic Head Cancer
Sign in / Sign up

Export Citation Format

Share Document